New hope for Alzheimer’s sufferers as FDA gives fast-track approval to experimental drug

New hope for Alzheimer’s sufferers as FDA gives fast-track approval to experimental drug

The study also showed that Leqembi carries a risk of brain swelling and bleeding

Subscribe
Notify of
guest
5 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
isototo
isototo
1 year ago

I appreciate the way you approach this topic with a sense of curiosity and openness. It’s clear you’re not afraid to ask difficult questions and challenge the status quo.

syair hongkong
syair hongkong
11 months ago

I agree with many of the points you make in this article and appreciate a different viewpoint.

paus4d
paus4d
11 months ago

Your article is a great contribution to the conversation around this topic. Thank you for sharing your insights.

Paus4d
Paus4d
10 months ago

This is a must-read article for anyone interested in this topic. Your writing is engaging and informative, and your ideas are well-supported with evidence.

Paus4d
Paus4d
10 months ago

Thank you for considering different viewpoints in this article.